Discovery of new Cdc2-like kinase 4 (CLK4) inhibitors via pharmacophore exploration combined with flexible docking-based ligand/receptor contact fingerprints and machine learning

Cdc2-like kinase 4 (CLK4) inhibitors are of potential therapeutic value in many diseases particularly cancer. In this study, we combined extensive ligand-based pharmacophore exploration, ligand–receptor contact fingerprints generated by flexible docking, physicochemical descriptors and machine learn...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Tawil, Mai Fayiz, Daoud, Safa, Hatmal, Ma'mon M., Taha, Mutasem Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2022
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982525/
https://www.ncbi.nlm.nih.gov/pubmed/35424985
http://dx.doi.org/10.1039/d2ra00136e

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982525/
https://www.ncbi.nlm.nih.gov/pubmed/35424985
http://dx.doi.org/10.1039/d2ra00136e

Ejemplares similares